Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 22, 2022 - Issue 1
Submit an article Journal homepage
755
Views
4
CrossRef citations to date
0
Altmetric
Systematic Review

Pembrolizumab plus lenvatinib or axitinib compared to nivolumab plus ipilimumab or cabozantinib in advanced renal cell carcinoma: a number needed to treat analysis

Matteo Santonia Oncology Unit, Macerata Hospital, Macerata, ItalyView further author information
,
Alessandro Rizzob Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, ItaliaView further author information
,
Veronica Mollicab Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, ItaliaView further author information
,
Matteo Rosellinib Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, ItaliaView further author information
,
Andrea Marchettib Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, ItaliaView further author information
,
Benedetta Fragomenob Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, ItaliaView further author information
,
Nicola Battellia Oncology Unit, Macerata Hospital, Macerata, ItalyView further author information
&
Francesco Massarib Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, ItaliaCorrespondence[email protected]
View further author information
 show all
Pages 45-51 | Received 30 Mar 2021, Accepted 27 May 2021, Published online: 15 Jun 2021

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Luciano Paladini, Cássia Rita Pereira da Veiga, Érica Cerqueira, Laura Chabrol Haas, Márcia Datz Abadi & Clarissa Seródio Baldotto. (2021) Number needed to treat analysis applied to pembrolizumab plus chemotherapy for first-line treatment of non-squamous non-small cell lung cancer. Journal of Medical Economics 24:1, pages 1185-1193.
Read now

Articles from other publishers (3)

Andrea Ossato, Daniele Mengato, Marco Chiumente, Andrea Messori & Vera Damuzzo. (2023) Progression-Free and Overall Survival of First-Line Treatments for Advanced Renal Cell Carcinoma: Indirect Comparison of Six Combination Regimens. Cancers 15:7, pages 2029.
Crossref
Matteo Santoni, Francesco Massari, Sergio Bracarda, Enrique Grande, Marc R. Matrana, Mimma Rizzo, Ugo De Giorgi, Umberto Basso, Gaetano Aurilio, Lorena Incorvaia, Angelo Martignetti, Javier Molina-Cerrillo, Veronica Mollica, Alessandro Rizzo & Nicola Battelli. (2022) Cabozantinib in Patients with Advanced Renal Cell Carcinoma Primary Refractory to First-line Immunocombinations or Tyrosine Kinase Inhibitors. European Urology Focus 8:6, pages 1696-1702.
Crossref
Veronica Mollica, Matteo Santoni, Marc R. Matrana, Umberto Basso, Ugo De Giorgi, Alessandro Rizzo, Marco Maruzzo, Andrea Marchetti, Matteo Rosellini, Sara Bleve, Diana Maslov, Karine Tawagi, Ernest Philon, Zoe Blake & Francesco Massari. (2021) Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell Carcinoma. Targeted Oncology 17:1, pages 61-68.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.